Leukemia Clinical Trials in Massachusetts

Showing 1161-1180 of 1,457 trials

Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer

NCT02406235

The overall objective of this study is to assess turnaround time, pre-BRCA test onco-genetic counselling quality and satisfaction with a new onco-genetic BRCA testing model.

Epithelial Ovarian/Fallopian Tube/Primary Peritoneal Cancer

AstraZeneca710 participantsStarted Apr 2015

San Francisco, California, United States • Gainesville, Florida, United States • Sarasota, Florida, United States +23 more locations

COMPLETEDPhase 1/214 miles

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies

NCT01606579

PRI-724 is a new investigational drug being studied to treat subjects with cancer who have advanced myeloid malignancies. PRI-724 is thought to work by blocking the Wnt signaling pathway that cancer cells need to grow and spread (metastasize).

Acute Myeloid LeukemiaChronic Myeloid Leukemia

Prism Pharma Co., Ltd.49 participantsStarted Jul 2012

Atlanta, Georgia, United States • Worcester, Massachusetts, United States • Albuquerque, New Mexico, United States +3 more locations

Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer

Safety and Efficacy Study of PRI-724 in Subjects With Advanced Myeloid Malignancies

Leukemia Trials in Other Cities

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia

Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery

S0802 - Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer

T Cell Effector and Regulatory Mechanisms in Asthma

Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)

MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia

Lenalidomide in Combination With Microtransplantation as Post-remission Therapy in AML

Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL)

PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)

Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer

Busulfan/Clofarabine + Allogeneic Stem Cell Transplantation

Emerging Adults Who Use Alcohol and Marijuana

OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission

Individual and Contextual Factors That Influence Sexual Decisions

Tecemotide Following Concurrent Chemo-radiotherapy for Non-small Cell Lung Cancer

Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model

A Multi-Center Study Evaluating the Safety of AC-170 0.24%

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia

Other Conditions in Massachusetts